Association between sarcopenic obesity, muscle strength and risk of cardiovascular and cardiometabolic diseases in the elderly: A systematic review
Keywords:
Cardiovascular diseases, Elderly, Metabolic diseases, Obesity, SarcopeniaAbstract
To describe the fi ndings in the literature about the association between sarcopenic obesity, muscle strength and risk factors and/or cardiometabolic or cardiovascular diseases in the elderly. A research was carried out in the following databases: Medical Literature Analysis and Retrievel System Online, Web of Science, Literatura Latino-Americana e do Caribe em Ciências da Saúde (Latin America and Caribbean Health Sciences Literature) and Capes Journals, using the following search terms in English, Spanish and Portuguese: “obesity sarcopenic” OR “sarcopenic obesity” in the title AND “cardiometabolic disease” OR “cardiovascular disease” OR “metabolic syndrome” OR “insulin resistance” in the title/abstract AND “aged” in all fields of search with the variation of the “muscle strength” descriptor in all fields of this research. Articles were selected according to the following exclusion criteria: studies evaluating only sarcopenia and the risk of cardiometabolic/cardiovascular disease in the elderly, studies evaluating only obesity and the risk of cardiometabolic/cardioascular disease in the elderly, studies that did not present the used method, studies in animals and studies that were not in Portuguese, English or Spanish. The researchers of the present study found a heterogeneity of methods for the identification of sarcopenic obesity, and a transversal cohort was used in most of the studies. It was possible to verify the association of sarcopenic obesity with risk factors and/or cardiometabolic or cardiovascular disease. Sarcopenic obesity is associated with risk factors and/or cardiometabolic or cardiovascular disease in the elderly. Establishing a robust definition of sarcopenic obesity in the elderly is necessary for further clinical studies and interventions.
References
Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology. 2008;9(4):213-28. http://dx.doi.org/10.1007/s10522-008-9131-0
Cruz-Jentoft AJ. Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412-23. http://dx.doi.org/10.1093/ageing/afq034
Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1-7. http://dx.doi.org/10.1097/MCO.0b013e328333c1c1
Kohara, K. Sarcopenic obesity in aging population: Current status and future directions for research. Endocrine. 2014;45(1):15-25. http://dx.doi.org/10.1007/s12020-013-9992-0
Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: Results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr. 2014;68(9):1001-7. http://dx.doi.org/10.1038/ejcn.2014.117
Levine ME, Crimmins EM. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity. 2012;20(10):2101-6. http://dx.doi.org/10.1038/oby.2012.20
Kohara K, Ochi M, Tabara Y, Nagai T, Igase M, Miki T. Leptin in sarcopenic visceral obesity: Possible link between adipocytes and myocytes. Plos One. 2011;6(9):e24633. http://dx.doi.org/10.1371/journal.pone.0024633
Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253-60. http://dx.doi.org/10.1111/jgs.12652
Kang SY, Lim GE, Kim YK, Kim HW, Lee K, Park TJ, et al. Association between sarcopenic obesity and metabolic syndrome in postmenopausal women: A cross-sectional study based on the Korean National Health and Nutritional Examination Surveys from 2008 to 2011. J Bone Metab. 2017;24(1):9-14. http://dx.doi.org/10.11005/jbm.2017.24.1.9
Takayama M, Azuma K, Hayashi K, Shimizu-Hirota R, Makino K, Bessho R, et al. Relationship between sarcopenic obesity and metabolic syndrome among Japanese elderly who underwent a comprehensive health checkup. Health Evaluation and Promotion. 2017;44(4):587-93. http://dx.doi.org/10.7143/jhep.44.587
Sena MHG, Silva KC, Medeiros JMB, Daltro CHC. Association between sarcopenic obesity and cardiovascular risk: Where are we? Nutr Hosp. 2016;33(5):1245-56. http://dx.doi.org/10.20960/nh.592
Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging. 2009;13(5):460-6. http://dx.doi.org/10.1007/s12603-009-0084-z
Schaap LA, Pluijm SM, Deeg DJ, Visser, M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526-e9-17. http://dx.doi.org/10.1016/j.amjmed.2005.10.049
Zamboni A, Di Thommazo A, Hernandes E, Fabbri SCPF. StArt uma ferramenta computacional de apoio à revisão sistemática. Congresso Brasileiro de Software; abr 2010 [citado 15 mar 2019]; Salvador; 2010. Disponível em: https://homes.dcc.ufba.br/~flach/docs/Ferramentas-CBSoft-2010.pdf
Baumgartner RN. Body composition in healthy aging. Ann NY Acad Sci. 2000;904(1):437-48. http://dx.doi.org/10.1111/j.1749-6632.2000.tb06498.x
Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, et al. Sarcopenic obesity: Prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010;33(7):1652-4. http://dx.doi.org/10.2337/dc10-0107
Hwang B, Lim JY, Lee J, Choi NK, Ahn YO, Park BJ. Prevalence rate and associated factors of sarcopenic obesity in Korean elderly population. J Korean Med Sci. 2012;27(7):748-55. http://dx.doi.org/10.3346/jkms.2012.27.7.748
Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. Sarcopenia: Alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51(11):1602-9. http://dx.doi.org/10.1046/j.1532-5415.2003.51534.x
Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96. http://dx.doi.org/10.1046/j.1532-5415.2002.50216.x
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95-101. http://dx.doi.org/10.1016/j.jamda.2013.11.025
McLean RR, Shardell MD, Alley DE, Cawthon PM, Fragala MS, Harris TB, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: The foundation for the National Institutes of Health (FNIH) Sarcopenia Project. J Gerontol A Biol Sci Med Sci. 2014;69(5):576-83. http://dx.doi.org/doi:10.1093/gerona/glu012
Sanada K, Chen R, Willcox B, Ohara T, Wen A, Takenaka C, Masaki, K. Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: The Kuakini Honolulu Heart Program. Nutrition. 2018;46:97-102. http://dx.doi.org/10.1016/j.nut.2017.09.003
Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: A focus on sarcopenic obesity. Arch Gerontol Geriatr. 2013;56(1):270-8. http://dx.doi.org/10.1016/j.archger.2012.09.007
Lu CW, Yang KC, Chang HH, Lee LT, Chen CY, Huang KC. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301-e307. http://dx.doi.org/10.1016/j.orcp.2012.02.003
Wittmann K, Sieber C, Von Stengel S, Kohl M, Freiberger E, Jakob F, et al. Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: The randomized controlled FORMOsA-Sarcopenic Obesity Study. Clin Interv Aging. 2016;11:1697-706. http://dx.doi.org/10.2147/CIA.S116430/
Santos EP, Gadelha AB, Safons MP, Nóbrega OT, Oliveira RJ, Lima RM. Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women. Arch Gerontol Geriatr. 2014;59(1):56-61. http://dx.doi.org/10.1016/j.archger.2014.03.012
Levine ME, Crimmins EM. Sarcopenic obesity and cognitive functioning: The mediating roles of insulin resistance and inflammation. Curr Gerontol Geriatr Res. 2012;2012:iD826398. http://dx.doi.org/10.1155/2012/826398
Yang CW, Li CI, Li TC, Liu CS, Lin CH, Lin WY, et al. Association of sarcopenic obesity with higher serum high-sensitivity c-reactive protein levels in Chinese older males: A community-based study (Taichung Community Health Study Elderly, TCHS-E). Plos One. 2015;10(7):e0132908. http://dx.doi.org/10.1371/journal.pone.0132908
Ohara M, Kohara K, Tabara Y, Ochi M, Nagai T, Igase M, et al. Sarcopenic obesity and arterial stiffness, pressure wave reflection and central pulse pressure: The J-SHIPP Study. Int J Cardiol. 2014;174(1):214-7. http://dx.doi.org/10.1016/j.ijcard.2014.03.194
Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in The InCHIANTI Study. J Appl Physiol. 2007;102(3):919-25. http://dx.doi.org/10.1152/japplphysiol.00627.2006
Park SH, Park JH, Song PS, Kim DK, Kim KH, Seol SH, et al. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens. 2013;7(6):420-5. http://dx.doi.org/10.1016/j.jash.2013.06.002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Luiz Sinésio SILVA NETO, Alessandra MEDEIROS, Andreia TRAVASSOS, Neila Barbosa OSÓRIO, Genildo Ferreira NUNES
This work is licensed under a Creative Commons Attribution 4.0 International License.